ShangPharma Q3 revenue rises 16.6%
According to ShangPharma, the revenue rises primarily due to a larger customer base, higher revenues from the company’s top customers, broader service offerings and higher average rate from
Made Scientific has acquired an 85,000ft² cell therapy manufacturing facility in Pennsylvania, US, from National Resilience, adding an operational site to its US East Coast network.